Pomelo Care is a technology company.
Pomelo Care is a leading virtual medical practice focused on maternal and women's health, providing 24/7 support for pregnancy and newborn care.
Pomelo Care has raised $79.0M across 2 funding rounds.
Pomelo Care has raised $79.0M in total across 2 funding rounds.
Pomelo Care is a virtual medical practice specializing in maternity and women's health, offering 24/7 access to multidisciplinary care teams via text, phone, video, and a digital app.[1][2][6] It serves patients through partnerships with health plans, employers (e.g., Mount Sinai Health System), Medicaid managed care organizations, and academic medical centers like Penn Medicine, targeting pre-conception, pregnancy, postpartum, and newborn care to address U.S. maternal health disparities.[1][2] The company solves high maternal and infant mortality rates—despite $111 billion annual U.S. spending—by providing value-based, technology-driven care that reduces emergency visits, complications, and costs while improving outcomes, especially for underserved groups.[2] Founded in 2021, it has raised $79.04M (latest $46M Series B), operates in 44 states, and expects to serve 2 million patients annually with strong growth momentum shown in recent funding and data-proven results.[1][2][4]
Pomelo Care was founded in 2021 by Marta Bralic Kerns, a clinician-turned-entrepreneur passionate about maternal health, emerging from stealth with $33M in seed and Series A funding led by Andreessen Horowitz (a16z) and First Round Capital, plus investors like SV Angel and BoxGroup.[1][2] Kerns launched the company to tackle the U.S.'s poor maternal outcomes—among the worst in developed nations, worsened by COVID-19 and disproportionately affecting women of color—by delivering high-quality care at home.[2] Early traction came from rapid expansion to 44 states, payer partnerships, and board additions like a16z's Vineeta Agarwala, M.D., Ph.D., and First Round's Josh Kopelman, fueling growth to cover over 3 million lives and publish outcome data.[2][4]
Pomelo stands out in virtual maternity care through its value-based, tech-enabled model emphasizing prevention and personalization:
Pomelo rides the digital health and value-based care wave in maternity, capitalizing on telehealth's post-COVID boom and payer shifts toward outcomes over volume.[2] Timing aligns with U.S. maternal mortality crises (highest among high-income nations) and regulatory pushes for equity, where tech bridges access gaps in fragmented women's health.[1][2] Market forces like rising healthcare costs ($111B/year on maternity) and employer benefits demand favor its model, influencing the ecosystem by setting benchmarks for virtual specialty care, reducing disparities, and inspiring similar tech-clinician hybrids in pediatrics and chronic care.[2][4]
Pomelo is poised for Series C funding and national scale, leveraging its $79M war chest, outcome data, and partnerships to hit 5M+ lives amid payer adoption of value-based maternity contracts.[1][4] Trends like AI-enhanced care coordination (hinted via its data science team) and Medicaid expansions will accelerate growth, potentially evolving it into a full-spectrum women's health platform.[5] As digital maternity matures, Pomelo could redefine family care standards, cutting U.S. disparities and proving tech's ROI in high-stakes health—echoing its origins in making elite care accessible to all.[2][6]
Pomelo Care has raised $79.0M in total across 2 funding rounds.
Pomelo Care's investors include Access Biotechnology, Alumni Ventures, Andreessen Horowitz, BoxOne Ventures, Builders VC, First Round Capital, Brendan Bulik-Sullivan, SeaX Ventures, SNR, Versant Ventures, ZAKA Ventures, Shinichiro Fuse.
Pomelo Care has raised $79.0M across 2 funding rounds. Most recently, it raised $46.0M Series B in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2024 | $46.0M Series B | Access Biotechnology, Alumni Ventures, Andreessen Horowitz, BoxOne Ventures, Builders VC, First Round Capital, Brendan Bulik-Sullivan, SeaX Ventures, SNR, Versant Ventures, ZAKA Ventures, Shinichiro Fuse, Varsha Rao | |
| Jun 1, 2023 | $33.0M Series A | Access Biotechnology, Alumni Ventures, Andreessen Horowitz, BoxOne Ventures, Builders VC, First Round Capital, Brendan Bulik-Sullivan, SeaX Ventures, SNR, Versant Ventures, ZAKA Ventures, Shinichiro Fuse, Varsha Rao |